Cryoport Inc (CYRX) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.008x

Based on the latest financial reports, Cryoport Inc (CYRX) has a cash flow conversion efficiency ratio of 0.008x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($3.73 Million) by net assets ($494.99 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Cryoport Inc balance sheet independence to measure how much of total assets are equity-financed.

Cryoport Inc - Cash Flow Conversion Efficiency Trend (2004–2025)

This chart illustrates how Cryoport Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Cryoport Inc (CYRX) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Cryoport Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cryoport Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Placoplatre SA
PA:MLPLC
N/A
Zhang Xiaoquan Inc.
SHE:301055
N/A
Fujian MinDong Electric Power Co Ltd
SHE:000993
0.064x
Mobilicom Limited Warrants
NASDAQ:MOBBW
-0.038x
iQIYI Inc
F:IQ8
0.004x
GCM Grosvenor Inc
NASDAQ:GCMG
0.423x
Barco NV
BR:BAR
0.033x
Wuhan LinControl Automotive Electronics Co. Ltd. A
SHG:688667
0.053x

Annual Cash Flow Conversion Efficiency for Cryoport Inc (2004–2025)

The table below shows the annual cash flow conversion efficiency of Cryoport Inc from 2004 to 2025. For the full company profile with market capitalisation and key ratios, see CYRX market cap.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $502.64 Million $-8.58 Million -0.017x +57.97%
2024-12-31 $401.90 Million $-16.32 Million -0.041x -2523.72%
2023-12-31 $489.02 Million $-757.00K -0.002x +53.52%
2022-12-31 $555.84 Million $-1.85 Million -0.003x -126.30%
2021-12-31 $641.83 Million $8.13 Million 0.013x +132.59%
2020-12-31 $382.70 Million $-14.87 Million -0.039x -270.50%
2019-12-31 $126.28 Million $-1.32 Million -0.010x +87.94%
2018-12-31 $38.55 Million $-3.35 Million -0.087x +56.59%
2017-12-31 $17.89 Million $-3.58 Million -0.200x +80.10%
2016-12-31 $5.68 Million $-5.72 Million -1.007x +20.32%
2015-12-31 $4.99 Million $-6.31 Million -1.264x -112.74%
2014-12-31 $-416.30K $-4.13 Million 9.915x +421.60%
2013-12-31 $-2.30 Million $-4.38 Million 1.901x -18.04%
2012-12-31 $-2.06 Million $-4.79 Million 2.319x +227.57%
2011-12-31 $3.73 Million $-6.78 Million -1.818x -124.76%
2010-12-31 $5.95 Million $-4.81 Million -0.809x -125.93%
2009-12-31 $-914.58K $-2.85 Million 3.120x +344.34%
2008-12-31 $-3.68 Million $-2.59 Million 0.702x +126.17%
2007-12-31 $-2.29 Million $-710.26K 0.310x -47.33%
2006-12-31 $-1.96 Million $-1.16 Million 0.589x +9.63%
2005-12-31 $-2.15 Million $-1.16 Million 0.538x -37.68%
2004-12-31 $-1.18 Million $-1.02 Million 0.863x --

About Cryoport Inc

NASDAQ:CYRX USA Integrated Freight & Logistics
Market Cap
$762.08 Million
Market Cap Rank
#10668 Global
#2799 in USA
Share Price
$15.12
Change (1 day)
+2.79%
52-Week Range
$7.72 - $16.57
All Time High
$83.29
About

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and biostorage, bioservices and cryopreservation services within the life science industry. Its Life Sciences Products segment manufactures, and sells cryogenic … Read more